Locations:
Search IconSearch
August 14, 2024/Innovations

Crain’s Cleveland Business: Centerline Biomedical Looks to Change ‘Current Gold Standard’ for Endovascular Intervention

Cleveland Clinic Innovations portfolio company Centerline Biomedical’s Intra-Operative Positioning System (IOPS) aims to help clinicians visualize endovascular tools in real-time and reduce their dependence on fluoroscopy systems.

Doctor with endovascular model

The use of fluoroscopy in orthopedic procedures presents a potential health risk to surgeons due to radiation exposure, even with the use of protective equipment. Centerline Biomedical, a Cleveland Clinic Innovations med-tech portfolio company, aims to address this issue with its Intra-Operative Positioning System (IOPS). Recently receiving FDA clearance for its IOPS Viewpoint Catheter, the company's technology aims to reduce reliance on fluoroscopy systems and protect clinicians from radiation exposure.

The IOPS system, based on electromagnetic tracking, creates real-time visualization of endovascular tools, offering a safer alternative to fluoroscopy. Developed as a collaboration between former Cleveland Clinic researcher Vikash Goel and the late Dr. Roy Greenberg, the technology aims to improve visualization during endovascular interventions and reduce the health risks associated with prolonged radiation exposure for surgeons.

Centerline Biomedical's IOPS system, designed to provide real-time navigation feedback, consists of a portable cart, electromagnetic field generator, sensor interface unit, and specially designed catheters and guidewires with integrated sensors. The company has been continually improving its system based on feedback from early adopters and is set to release new hardware and software updates, with plans for further upgrades in the coming years. In addition to reducing radiation exposure, the IOPS technology has the potential to enhance efficiency in the operating room, allowing doctors to work more effectively by providing clearer visualization. With the appointment of a new Chief Financial Officer and a successful $33 million Series B equity financing round in 2022, Centerline Biomedical is poised to further advance its mission of providing a safer and more efficient alternative to fluoroscopy for orthopedic procedures.

Read the full article via Crain’s Cleveland Business.

Subscribe to Cleveland Clinic Innovations' Newsletter

Follow Cleveland Clinic Innovations on LinkedIn

Latest from the Newsroom

Cleveland Clinic contributed $2.5 million to Second Harvest Food Bank of North Central Ohio.

Cleveland Clinic Expands Partnership with Second Harvest Through $2.5 Million Commitment

Image from a cardiac MRI.

Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy

Camille Ruvo (left) was presented with an award by Maria Shriver.

Camille Ruvo Honored for Advancing Alzheimer’s Research and Care at Global Women’s Health + WAM Forum

Cleveland Clinic donated $1.25 million to Children’s Hunger Alliance on Friday, May 15.

Cleveland Clinic Donates $1.25M to Children’s Hunger Alliance to Expand Preschool Nutrition Programs

Maria Shriver and Beri Ridgeway, M.D., at the Global Women’s Health + WAM Forum.

Cleveland Clinic Releases New National Report on the State of Women’s Health in the U.S.

Children dressed up for Cleveland Clinic Children’s annual Derby Soirée on May 2.

Cleveland Clinic Children’s Derby Soirée Raises More Than $6.5 Million to Support Pediatric Care and Research

The IBM Quantum System One at Cleveland Clinic is the world’s first quantum computer fully dedicated to healthcare research.

Cleveland Clinic, RIKEN, and IBM Model a 12,635-Atom Protein – the Largest Known to Be Simulated with Quantum Computers

Sad teen being comforted

Cleveland Clinic Children’s Unveils Program to Expand Access to Pediatric Mental Health Care